Cercosporin

Cercosporin

SCHEMBL28102616

COc1c(C[C@H](C)O)c2c3c(C[C@H](C)O)c(OC)c(=O)c4c(O)cc5c(c6c(cc(O)c(c1=O)c62)OCO5)c43.C[O]

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TCF4 P15884 5/20 0.70
CTNNB1 P35222 5/20 0.70
CDH1 P12830 1/20 0.70
APC P25054 1/20 0.70
TCF7L2 Q9NQB0 1/20 0.70
GAA P10253 2/20 0.35
MAPT P10636 1/20 0.35
ATM Q13315 1/20 0.35
CYP3A4 P08684 3/20 0.34
CYP2D6 P10635 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
ALOX15 P16050 1/20 0.34
CYP2C19 P33261 1/20 0.34
HDAC1 Q13547 1/20 0.34
P4HB P07237 3/20 0.33
SMPD1 P17405 1/20 0.33
CDK2 P24941 1/20 0.32
SMAD3 P84022 3/20 0.32
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cercosporin SCHEMBL498747 0.99 TCF4 (0.71) TCF4CTNNB1CDH1APCTCF7L2
Cercosporin SCHEMBL6305985 0.99 TCF4 (0.71) TCF4CTNNB1CDH1APCTCF7L2
Cercosporin SCHEMBL15185706 0.99 TCF4 (0.71) TCF4CTNNB1CDH1APCTCF7L2
Cercosporin SCHEMBL29613349 0.99 TCF4 (0.71) TCF4CTNNB1CDH1APCTCF7L2
Cercosporin SCHEMBL21175561 0.93 TCF4 (0.65) TCF4CTNNB1CDH1APCTCF7L2
SCHEMBL22930428 0.92 TCF4 (0.64) TCF4CTNNB1CDH1APCTCF7L2
SCHEMBL29369377 0.82 CTNNB1 (1.00) TCF4CTNNB1CDH1APCTCF7L2
SCHEMBL13121634 0.80 CTNNB1 (0.49) TCF4CTNNB1CDH1APCTCF7L2
SCHEMBL8476647 0.71 TCF4 (0.42) TCF4CTNNB1CDH1APCTCF7L2
SCHEMBL29711267 0.65 CTNNB1 (0.68) TCF4CTNNB1CDH1APCTCF7L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102325550-B Photodynamic therapy and anti-vegf agent use in conjunction in the choroidal neovascular system that treatment is harmful QLT公司 2016-10-26 CN disclosed